200 related articles for article (PubMed ID: 34032536)
1. Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer.
Karlsson AT; Hjermstad MJ; Omdahl T; Aass N; Skovlund E; Hellebust TP; Johansen S; Kaasa S; Yri OE
Acta Oncol; 2021 Aug; 60(8):1054-1060. PubMed ID: 34032536
[TBL] [Abstract][Full Text] [Related]
2. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
4. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
[TBL] [Abstract][Full Text] [Related]
7. Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis.
Deng G; Zhang Y; Ke J; Wang Q; Qin H; Li J; Li Z
J Transl Med; 2021 Nov; 19(1):486. PubMed ID: 34847914
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
9. Whole brain radiotherapy in management of non-small-cell lung carcinoma associated leptomeningeal carcinomatosis: evaluation of prognostic factors.
Ozdemir Y; Yildirim BA; Topkan E
J Neurooncol; 2016 Sep; 129(2):329-35. PubMed ID: 27306442
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO.
Scoccianti S; Olmetto E; Pinzi V; Osti MF; Di Franco R; Caini S; Anselmo P; Matteucci P; Franceschini D; Mantovani C; Beltramo G; Pasqualetti F; Bruni A; Tini P; Giudice E; Ciammella P; Merlotti A; Pedretti S; Trignani M; Krengli M; Giaj-Levra N; Desideri I; Pecchioli G; Muto P; Maranzano E; Fariselli L; Navarria P; Ricardi U; Scotti V; Livi L
Neuro Oncol; 2021 Oct; 23(10):1750-1764. PubMed ID: 34050669
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in patients with non-small cell lung carcinoma and brain metastases: a Malaysian perspective.
Tang WH; Alip A; Saad M; Phua VC; Chandran H; Tan YH; Tan YY; Kua VF; Wahid MI; Tho LM
Asian Pac J Cancer Prev; 2015; 16(5):1901-6. PubMed ID: 25773842
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series.
Fessart E; Mouttet Audouard R; Le Tinier F; Coche-Dequeant B; Lacornerie T; Tresch E; Scherpereel A; Lartigau E; Mirabel X; Pasquier D
Sci Rep; 2020 Jul; 10(1):11201. PubMed ID: 32641798
[TBL] [Abstract][Full Text] [Related]
13. Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):21. PubMed ID: 36717863
[TBL] [Abstract][Full Text] [Related]
14. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
[TBL] [Abstract][Full Text] [Related]
15. Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with one to three brain metastases and favorable prognoses: a secondary analysis of EORTC 22952-26001.
Churilla TM; Handorf E; Collette S; Collette L; Dong Y; Aizer AA; Kocher M; Soffietti R; Alexander BM; Weiss SE
Ann Oncol; 2017 Oct; 28(10):2588-2594. PubMed ID: 28961826
[TBL] [Abstract][Full Text] [Related]
16. A matched-pair analysis comparing stereotactic radiosurgery with whole-brain radiotherapy for patients with multiple brain metastases.
El Shafie RA; Celik A; Weber D; Schmitt D; Lang K; König L; Bernhardt D; Höne S; Forster T; von Nettelbladt B; Adeberg S; Debus J; Rieken S
J Neurooncol; 2020 May; 147(3):607-618. PubMed ID: 32239433
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases.
Deng X; Zheng Z; Lin B; Su H; Chen H; Fei S; Fei Z; Zhao L; Jin X; Xie CY
BMC Cancer; 2017 Jan; 17(1):42. PubMed ID: 28068937
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer.
Tsakonas G; Hellman F; Gubanski M; Friesland S; Tendler S; Lewensohn R; Ekman S; de Petris L
Acta Oncol; 2018 Feb; 57(2):231-238. PubMed ID: 28984492
[TBL] [Abstract][Full Text] [Related]
20. Whole brain radiotherapy (WBRT) for leptomeningeal metastasis from NSCLC in the era of targeted therapy: a retrospective study.
Zhen J; Wen L; Lai M; Zhou Z; Shan C; Li S; Lin T; Wu J; Wang W; Xu S; Liu D; Lu M; Zhu D; Chen L; Cai L; Zhou C
Radiat Oncol; 2020 Jul; 15(1):185. PubMed ID: 32736566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
